Although T1D mainly results from T-lymphocyte mediated destruction of insulin producing beta cells within pancreatic islets, appearance of IAbs that develop years before clinical disease are currently the most reliable biomarkers for T1D prediction and clinical diagnosis. The gene discussed is INS; the disease is type 1 diabetes mellitus.